CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Redx tries again at reverse merger, with Skye this time, as route gains steam

Positive
AI Analysis

Summary

UK fibrosis biotech Redx Pharma is pursuing a reverse merger with Skye to obtain a Nasdaq listing, marking a second attempt after a prior deal fell through in 2023.

Importance:6/10
Sentiment:
0.30
reverse mergerROCK inhibitorNasdaq listingfibrosis
Related Companies

Read the original article

Published by Endpoints News on August 14, 2026 3:30 PM

Read Original